Peter Zdziarski/LinkedIn
Apr 13, 2026, 17:41
Peter Zdziarski: Glanzmann’s Research Foundation Listed as GT Patient Organization on NORD
Peter Zdziarski, Founder and Marketing Director of Glanzmann Thrombasthenia Advocacy Network, shared a post on LinkedIn:
“Proud to share that the Glanzmann’s Research Foundation, Inc. is now listed as a patient organization for GT on the National Organization for Rare Disorders website.
This is a meaningful step in helping more individuals and families affected by Glanzmann Thrombasthenia find trusted information and a supportive community of actual patients that much sooner.
Grateful to NORD for the work they do to elevate rare disease organizations and connect people to the resources they need.”
More posts featuring Peter Zdziarski on Hemostasis Today.
-
May 31, 2026, 16:29José Antonio García Erce: Collaborative PBM Implementation in Transfusion Centers and Services
-
May 31, 2026, 16:22Vera Ignjatović: How Do We Rigorously Study These Drugs in Children to Understand Their True Benefits and Risks?
-
May 31, 2026, 16:21Ksenija Stach: Is This The Future of Lipid-Lowering Lherapy?
-
May 31, 2026, 15:42Antonio Greco: Balancing Bleeding and Thrombotic Risk After PCI
-
May 31, 2026, 15:41Eric Topol: Replication of Plasma p-tau217 Blood Test for Predicting Alzheimer’s Disease
-
May 31, 2026, 15:32ASH Invites Dynamic Members to Apply for 2027 Leadership and Committee Roles
-
May 31, 2026, 14:39Monique Gore-Massy: Redefining Lupus Innovation Through Patient Partnership
-
May 31, 2026, 14:31Mirjam Teboe: The Golden Rule Behind Reliable Lupus Anticoagulant Testing
-
May 31, 2026, 14:20Improving Access to Care for People Living with Haemophilia and Haemoglobinopathies – NNHF